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Abstract
Background: Homozygosity or compound heterozygosity for coding region mutations of the
hemojuvelin gene (HJV) in whites is a cause of early age-of-onset iron overload (juvenile
hemochromatosis), and of hemochromatosis phenotypes in some young or middle-aged adults. HJV
coding region mutations have also been identified recently in African American primary iron
overload and control subjects. Primary iron overload unexplained by typical hemochromatosis-
associated HFE genotypes is common in white and black adults in Alabama, and HJV I222N and
G320V were detected in a white Alabama juvenile hemochromatosis index patient. Thus, we
estimated the frequency of the HJV missense mutations I222N and G320V in adult whites and
African Americans from Alabama general population convenience samples.
Methods: We evaluated the genomic DNA of 241 Alabama white and 124 African American adults
who reported no history of hemochromatosis or iron overload to detect HJV missense mutations
I222N and G320V using polymerase chain reaction-restriction fragment length polymorphism
(PCR-RFLP) technique. Analysis for HJV I222N was performed in 240 whites and 124 African
Americans. Analysis for HJV G320V was performed in 241 whites and 118 African Americans.
Results: One of 240 white control subjects was heterozygous for HJV I222N; she was also
heterozygous for HFE C282Y, but had normal serum iron measures and bone marrow iron stores.
HJV I222N was not detected in 124 African American subjects. HJV G320V was not detected in 241
white or 118 African American subjects.
Conclusions: HJV I222N and G320V are probably uncommon causes or modifiers of primary iron
overload in adult whites and African Americans in Alabama. Double heterozygosity for HJV I222N
and HFE C282Y may not promote increased iron absorption.
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Background
Homozygosity or compound heterozygosity for coding
region mutations of the hemojuvelin gene (HJV) in whites
is a cause of early age-of-onset iron overload (juvenile
hemochromatosis), and of hemochromatosis phenotypes
in some young or middle-aged adults [1-4]. HJV coding
region mutations have also been identified recently in
African American primary iron overload and control sub-
jects [5]. We estimated the frequency of the HJV missense
mutations I222N and G320V in Alabama white and Afri-
can American adults who reported no history of hemo-
chromatosis or iron overload, because primary iron
overload unexplained by typical hemochromatosis-asso-
ciated HFE genotypes is common in whites and blacks in
Alabama [6-8], and HJV I222N and G320V were detected
in an Alabama juvenile hemochromatosis index patient
[3]. In addition, HJV  I222N and G320V have been
described in white adults with hemochromatosis pheno-
types in other geographic areas [1,2,9].
Methods
General criteria for selection of study subjects
Performance of this study was approved by the Institu-
tional Review Boards of the University of Alabama at Bir-
mingham and Brookwood Medical Center. Unrelated
white subjects were spouses of patients who attended a
hematology and medical oncology outpatient clinic; hos-
pital employees; and controls who participated in a sleep
study. Unrelated control black subjects were spouses of
patients who attended a hematology and medical oncol-
ogy outpatient clinic; hospital employees; controls who
participated in a sleep study; and controls who partici-
pated in a study of gestational diabetes mellitus. All sub-
jects were adults (≥ 18 years old). No subject reported a
previous diagnosis of hemochromatosis or iron overload.
Serum transferrin saturation, serum ferritin concentra-
tion, or other indicators of iron metabolism were not
measured in most study subjects.
Polymerase chain reaction-restriction fragment length 
polymorphism (PCR-RFLP) analyses
Genomic DNA was isolated from blood buffy coat as
described previously [6]. HJV I222N and G320V were gen-
otyped by standard PCR-RFLP and agarose electrophoresis
techniques. Exon 4 of the HJV locus was amplified using
the primers HJEx4AF and HJEx4BR previously described
[3]; this allowed for the amplification of the region con-
taining both the I222N and G320V mutations of the HJV
locus. Reaction conditions were as follows: 10 mM KCl,
10 mM (NH4)2SO4, 20 mM Tris-HCl (pH 8.8), 0.1% Tri-
ton X-100, 3.2 mM MgSO4, 200 µM dATP, 200 µM dCTP,
200 µM dGTP, 200 µM dTTP, 1 µM of each primer, 0.2 U/
µL of Taq Polymerase. Amplification conditions on a
Biometra UNO II thermocycler (LabRepCo/LabRepNet,
Horsham, PA) consisted of an initial denaturing at 94°C
for five minutes followed by thirty cycles of 94°C for 30
seconds, 60°C for 30 seconds and 72°C for 30 seconds.
Delineation of c.665T→A of the HJV exon 4 nucleotide
sequence defining I222N was made utilizing the restric-
tion endonuclease Bcc I (New England Biolabs, Beverly,
MA), which recognizes the nucleotide c.665T of I222 as a
restriction site, and not the nucleotide c.665A of N222.
Similarly, the nucleotide polymorphism site c.959G→T
defining the G320V polymorphism of the HJV  exon 4
locus was determined by using the restriction endonucle-
ase Ban I (New England Biolabs, Beverly, MA). Ban I rec-
ognizes the nucleotide c.959G of G320 as part of the
restriction site sequence, but not the nucleotide c.959T of
V320. DNA specimens from the parents of a white juve-
nile hemochromatosis index case were used as positive
controls for HJV I222N and G320V [3].
Statistical considerations
The data set consisted of observations on 241 Alabama
white and 124 African American adults. Analysis for HJV
I222N was performed in 240 whites and 124 African
Americans. Analysis for HJV G320V was performed in 241
whites and 118 African Americans. Results are expressed
as allele frequencies and 95% confidence intervals (CI).
To estimate the CI for frequencies of HJV mutations that
were not detected in the present subjects, we computed
the allele frequency as the quotient of single minimal
hypothetical value (= 0.01) and the number of chromo-
somes corresponding to the respective groups of subjects.
Computations were performed with GB-STAT (v10.0;
Dynamic Microsystems, Inc., Silver Spring, MD).
Results
Allele frequencies of HJV I222N and G320V
These results are displayed in Table 1. One of 240 white
subjects was heterozygous for HJV I222N, but this muta-
tion was not detected in African American subjects. HJV
G320V was not detected in either white or African Ameri-
can subjects.
Characteristics of a HJV I222N heterozygote
Medical records of the white subject heterozygous for HJV
I222N were available for review. This 29 year-old woman
was also heterozygous for HFE C282Y. She reported that
she had had two normal pregnancies and one spontane-
ous abortion. She has always experienced heavy men-
strual flow, but she reported no other significant blood
loss. She reported no blood donation. She reported that
she eats a variety of meats, vegetables, and other foods;
there was no history of supplemental iron ingestion. Her
hemoglobin level was 12.8 g/dL, platelets 113,000/mm3,
transferrin saturation 21%, and serum ferritin 23 ng/mL;
marrow examination performed to evaluateBMC Medical Genetics 2004, 5:29 http://www.biomedcentral.com/1471-2350/5/29
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thrombocytopenia revealed normal cellular morphology
and normal iron stores.
Discussion
A variety of HJV  coding region mutations occur in
homozygous or compound heterozygous configuration in
persons with juvenile or adult-onset hemochromatosis
phenotypes [1-5,9-11]. However, these types of HJV-asso-
ciated hemochromatosis are collectively uncommon [1-
3,11,12]. HJV mutations were also uncommon in control
whites studied with dHPLC (denaturing high-perform-
ance liquid chromatography) [9]. In 200 Greek volunteer
blood donors, none carried the HJV  G320V mutation
detectable by PCR-RFLP analysis, suggesting that the fre-
quency of the G320V allele in the Greek population is
lower than 0.004 [11]. In French control subjects, for
example, only the HJV missense mutations L101P (two
heterozygotes) and E302K (one heterozygote) were iden-
tified in 333 control subjects, representing an aggregate
HJV mutation frequency of 0.0045 (95% CI: 0, 0.0096)
[9]. The present results in Alabama white control subjects
are consistent with these previous reports. Taken together,
these observations confirm and extend previous observa-
tions that the individual or aggregate frequency of HJV
coding region mutations is low in general populations of
whites [9].
Heterozygosity for a HJV missense mutation was associ-
ated with increased severity of iron overload in nine of
310 French patients with hemochromatosis and HFE
C282Y homozygosity who were studied with dHPLC [9].
In 48 white U.S. hemochromatosis patients with HFE
C282Y homozygosity studied with dHPLC, no HJV cod-
ing region mutation was detected [5]. Thus, aggregate HJV
coding region mutation frequencies in C282Y homozy-
gotes with a hemochromatosis phenotype in France and
the U.S. are similar (0.0148 vs. 0, respectively; p = 0.2716,
Fisher exact test). The aggregate frequency of HJV coding
region mutations was similar in French hemochromatosis
patients with HFE C282Y homozygosity and in French
control subjects (0.0145 vs. 0.0045, respectively; p =
0.0564, Fisher exact test), although the hemochromatosis
patients with HJV  coding region mutations had more
severe iron overload, on the average, than did hemochro-
matosis patients without HJV coding region mutations
[9].
Double heterozygosity for HJV I222N and HFE C282Y
was not associated with evidence of increased iron absorp-
tion in the present case. Some persons with JH have com-
mon  HFE  genotypes, including C282Y heterozygosity,
H63D heterozygosity or homozygosity, and S65C hetero-
zygosity [13-18]. However, these HFE genotypes are infre-
quently associated with a severe hemochromatosis
phenotype [6,7,19-25]. Further, sequencing HFE introns
and exons in English and French Canadian JH cases did
not reveal novel HFE mutations that could likely explain
the development of iron overload [14,15]. In 310 C282Y
homozygotes in France, HJV  mutations were relatively
common and were associated with greater severity of iron
overload [9]. In 48 C282Y homozygotes in the U.S. who
had severe iron overload phenotypes, no HJV  coding
region mutation was detected [5]. The frequency of H63D
is significantly greater in persons with cardiomyopathy
than in normal control subjects [26]. The brother of a
Spanish JH proband had evidence of iron overload associ-
ated with H63D homozygosity and heterozygosity for a
putative JH-associated Ch1q haplotype [17]. Although
these reports are consistent with observations in another
JH patient with cardiomyopathy who had HFE  H63D
[3,12], other persons with JH and cardiomyopathy did
not have H63D [15]. Altogether, these reports indicate
that further exploration of the potential role of variant
HJV alleles in the clinical expression of iron overload with
particular reference to HFE  hemochromatosis is war-
ranted [2], and that the frequency and biological signifi-
cance of HJV alleles may vary among racial/ethnic groups.
Primary iron overload in African Americans is phenotypi-
cally and genetically heterogeneous [8]. Some patients
Table 1: HJV missense mutations in Alabama adult subjects from the general population.1
HJV mutation I222N G320V
Whites tested, n 240 241
Whites with mutation, n 1 (heterozygote) 0
Allele frequency (95% CI) 0.0021 (0, 0.0062) 0 (0, ~0.00006)
African Americans tested, n 124 118
African Americans with mutation, n 0 0
Allele frequency (95% CI) 0 (0, ~0.00012) 0 (0, ~0.00013)
1HJV mutations were detected using PCR-RFLP technique. DNA specimens from the parents of a white juvenile hemochromatosis index case were 
used as positive controls for HJV I222N and G320V [3]. CI = confidence interval.BMC Medical Genetics 2004, 5:29 http://www.biomedcentral.com/1471-2350/5/29
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have common HFE mutations, a common allele of the fer-
roportin gene (FPN1 Q248H), or heritable types of ane-
mia [8,27,28], but the genetic basis of most cases remains
unknown. HJV I222N and G320V were not detected in the
present African American subjects. However, HJV coding
region mutations were recently identified in two of 51
African American subjects with iron overload: exon 3, nt
205–207 ins GGA (ins G69) (frequency 0.0098); and
exon 4, nt 929 C→G (A310G) (allele frequency 0.0196)
[5]. The HJV alleles ins G69 and A310G were also identi-
fied in African American control subjects (allele frequen-
cies 0.0038 and 0.0720, respectively) [5]. Taken together,
these observations suggest that HJV coding region muta-
tions are uncommon in African Americans, but may
account for some cases of primary iron overload [5].
Conclusions
HJV I222N and G320V are uncommon causes or modifi-
ers of primary iron overload in adult whites and African
Americans in Alabama. Double heterozygosity for HJV
I222N and HFE C282Y may not promote increased iron
absorption.
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